Keywords
Last Name
Institution

BEVERLY CAROL HANDY

TitleAssociate Professor
InstitutionMD Anderson
DepartmentLaboratory Medicine
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Peacock WF, Baumann BM, Bruton D, Davis TE, Handy B, Jones CW, Hollander JE, Limkakeng AT, Mehrotra A, Than M, Ziegler A, Dinkel C. Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome. JAMA Cardiol. 2018 Feb 01; 3(2):104-111. PMID: 29238804.
      View in: PubMed
    2. Cao L, Chen M, Phipps RA, Del Guidice RE, Handy BC, Wagar EA, Meng QH. Causes and impact of specimen rejection in a clinical chemistry laboratory. Clin Chim Acta. 2016 Jul 01; 458:154-8. PMID: 27166198.
      View in: PubMed
    3. Meng QH, Handy BC, Wagar EA. Falsely elevated tacrolimus concentrations on the Dimension Xpand. Clin Biochem. 2015 Nov; 48(16-17):1210. PMID: 26160209.
      View in: PubMed
    4. Giuliano M, Giordano A, Jackson S, De Giorgi U, Mego M, Cohen EN, Gao H, Anfossi S, Handy BC, Ueno NT, Alvarez RH, De Placido S, Valero V, Hortobagyi GN, Reuben JM, Cristofanilli M. Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination. Breast Cancer Res. 2014; 16(5):440. PMID: 25223629; PMCID: PMC4303121.
    5. Meng QH, Handy B, Wagar E. A case of green blood. Clin Chem. 2014 Apr; 60(4):695-6. PMID: 24682689.
      View in: PubMed
    6. Alexanian R, Wang M, Delasalle K, Wang S, Qazilbash M, Handy B, Weber D. Value of novel agents and intensive therapy for patients with multiple myeloma. Bone Marrow Transplant. 2014 Mar; 49(3):422-5. PMID: 24317125.
      View in: PubMed
    7. Meng QH, Handy B, Wagar EA. It's not easy being blue-green. Ann Lab Med. 2013 Nov; 33(6):457-8. PMID: 24205497.
      View in: PubMed
    8. Meng QH, Handy B, Wagar E. Confirmatory testing of urine ketones and bilirubin: still necessary? Arch Pathol Lab Med. 2013 Aug; 137(8):1028-9. PMID: 23899056.
      View in: PubMed
    9. Dean-Colomb W, Hess KR, Young E, Gornet TG, Handy BC, Moulder SL, Ibrahim N, Pusztai L, Booser D, Valero V, Hortobagyi GN, Esteva FJ. Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer. Breast Cancer Res Treat. 2013 Jan; 137(2):631-6. PMID: 23242617.
      View in: PubMed
    10. Paxton RJ, Garcia-Prieto C, Berglund M, Hernandez M, Hajek RA, Handy B, Brown J, Jones LA. A randomized parallel-group dietary study for stages II-IV ovarian cancer survivors. Gynecol Oncol. 2012 Mar; 124(3):410-6. PMID: 22119991; PMCID: PMC3278555.
    11. Giordano A, Giuliano M, De Laurentiis M, Arpino G, Jackson S, Handy BC, Ueno NT, Andreopoulou E, Alvarez RH, Valero V, De Placido S, Hortobagyi GN, Reuben JM, Cristofanilli M. Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy. Ann Oncol. 2012 May; 23(5):1144-50. PMID: 21965473.
      View in: PubMed
    12. Giuliano M, Giordano A, Jackson S, Hess KR, De Giorgi U, Mego M, Handy BC, Ueno NT, Alvarez RH, De Laurentiis M, De Placido S, Valero V, Hortobagyi GN, Reuben JM, Cristofanilli M. Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Res. 2011; 13(3):R67. PMID: 21699723; PMCID: PMC3218956.
    13. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, Giannitsis E, Gustafson S, Handy B, Katus H, Melanson SE, Panteghini M, Venge P, Zorn M, Jarolim P, Bruton D, Jarausch J, Jaffe AS. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011 Apr 11; 412(9-10):748-54. PMID: 21219893.
      View in: PubMed
    14. Mego M, De Giorgi U, Dawood S, Wang X, Valero V, Andreopoulou E, Handy B, Ueno NT, Reuben JM, Cristofanilli M. Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells. Int J Cancer. 2011 Jul 15; 129(2):417-23. PMID: 20857493.
      View in: PubMed
    15. De Giorgi U, Mego M, Rohren EM, Liu P, Handy BC, Reuben JM, Macapinlac HA, Hortobagyi GN, Cristofanilli M, Ueno NT. 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer. J Nucl Med. 2010 Aug; 51(8):1213-8. PMID: 20660382.
      View in: PubMed
    16. Handy BC. Accelerating Development and Advancing Personalized Therapy (ADAPT) Congress. Washington, DC, USA, 22-25 September 2009. Biomark Med. 2010 Feb; 4(1):129-31. PMID: 20387309.
      View in: PubMed
    17. Mego M, De Giorgi U, Broglio K, Dawood S, Valero V, Andreopoulou E, Handy B, Reuben JM, Cristofanilli M. Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients. Br J Cancer. 2009 Dec 1; 101(11):1813-6. PMID: 19888227; PMCID: PMC2788266.
    18. Wang M, Delasalle K, Feng L, Thomas S, Giralt S, Qazilbash M, Handy B, Lee JJ, Alexanian R. CR represents an early index of potential long survival in multiple myeloma. Bone Marrow Transplant. 2010 Mar; 45(3):498-504. PMID: 19633690.
      View in: PubMed
    19. De Giorgi U, Valero V, Rohren E, Mego M, Doyle GV, Miller MC, Ueno NT, Handy BC, Reuben JM, Macapinlac HA, Hortobagyi GN, Cristofanilli M. Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Ann Oncol. 2010 Jan; 21(1):33-9. PMID: 19602564.
      View in: PubMed
    20. De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol. 2009 Jul 10; 27(20):3303-11. PMID: 19451443.
      View in: PubMed
    21. Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, Jackson S, Hortobagyi GN, Fritsche H, Cristofanilli M. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer. 2008 Nov 1; 113(9):2422-30. PMID: 18785255.
      View in: PubMed
    22. Davis JW, Nakanishi H, Kumar VS, Bhadkamkar VA, McCormack R, Fritsche HA, Handy B, Gornet T, Babaian RJ. Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. J Urol. 2008 Jun; 179(6):2187-91; discussion 2191. PMID: 18423725.
      View in: PubMed
    23. Wang M, Giralt S, Delasalle K, Handy B, Alexanian R. Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma. Hematology. 2007 Jun; 12(3):235-9. PMID: 17558699.
      View in: PubMed
    24. Yin CC, Lin P, Carney DA, Handy BC, Rassidakis GZ, Admirand JH, Keating MJ, Medeiros LJ. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol. 2005 Apr; 123(4):594-602. PMID: 15743747.
      View in: PubMed
    25. Lin P, Hao S, Handy BC, Bueso-Ramos CE, Medeiros LJ. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients. Am J Clin Pathol. 2005 Feb; 123(2):200-5. PMID: 15842043.
      View in: PubMed
    26. Alexanian R, Weber D, Delasalle K, Handy B, Champlin R, Giralt S. Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma. Bone Marrow Transplant. 2004 Aug; 34(3):229-34. PMID: 15170166.
      View in: PubMed
    27. Paul S, Karle S, Planque S, Taguchi H, Salas M, Nishiyama Y, Handy B, Hunter R, Edmundson A, Hanson C. Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120. J Biol Chem. 2004 Sep 17; 279(38):39611-9. PMID: 15269209.
      View in: PubMed
    28. Handy BC. Urinary beta2-microglobulin masquerading as a Bence Jones protein. Arch Pathol Lab Med. 2001 Apr; 125(4):555-7. PMID: 11260637.
      View in: PubMed
    29. Dasgupta A, Handy BC, Datta P. Mathematical models to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase. Am J Clin Pathol. 2000 Jan; 113(1):87-92. PMID: 10631861.
      View in: PubMed
    30. Tuite M, Ketonen L, Kieburtz K, Handy B. Efficacy of gadolinium in MR brain imaging of HIV-infected patients. AJNR Am J Neuroradiol. 1993 Jan-Feb; 14(1):257-63. PMID: 8427101.
      View in: PubMed
    31. Causes and impact of specimen rejection in a clinical chemistry laboratory. Clinica Chimica Acta. 458:154-158.
    32. Clinical applications of nanotechnology to cancer diagnostics and therapeutics. Journal of Clinical Ligand Assay. 29:124-129.
    33. The clinical utility of tumor markers. Laboratory Medicine. 40:99-103.
    34. Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Annals of Oncology. 21:33-39.
    35. Detection and prognostic significance of circulating tumor cells in patients with metastatic thyroid cancer. Journal of Clinical Endocrinology and Metabolism. 101:4461-4467.
    36. Evaluation of potassium values in a cancer patient population. Laboratory Medicine. 36:95-97.
    HANDY's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description